• 1
    Monday to Friday
    8am – 4:30pm
    3661 Valley Centre Dr
    Suite 100, San Diego, CA 92130

    Gender Selection Through Embryo Screening

    Advancements in infertility technology now allows intended parents to safely select the sex of their unborn child.  While the majority of anticipating parents would be happy with either a boy or girl, in some instances an individual or  couple may want to predetermine the gender.

    Sex selection is an option for those who want to avoid passing sex-linked genetic disorders to their children, such as Duchenne muscular dystrophy or hemophilia, a  bleeding disorder that slows the blood clotting process.

    Sex selection also might appeal to parents who have children of one sex and want to have a child of the other sex, or what is sometimes referred to as “family balancing.” Through Pre-implantation Genetic Screening (PGS) in conjunction with In Vitro Fertilization (IVF) process, doctors can determine the sex of the embryo, as well as its health to increase the likelihood of a successful pregnancy.

    PGS is a comprehensive chromosome embryo screening that examines embryos for chromosomal abnormalities. All 24 chromosomes (22 autosomes plus X and Y) are examined to evaluate any gains or losses of chromosomes, also known as aneuploidy. PGS is almost 100-percent accurate (99.9%) at determining the sex of an embryo.

    In addition to identifying the sex of an embryo, PGS increases the likelihood to achieve a healthy baby as it:

    • Reduces the likelihood of miscarriage and increases likelihood of successful implantation by identifying healthy embryos
    • Decreases the likelihood of abnormal pregnancy
    • Reduces the lost of time and incurred additional ivf gender selection cost with multiple IVF cycles
    • Identifies clinical alterations include extra copy of chromosome